{
    "Trade/Device Name(s)": [
        "VivaChek\u2122 Fad Blood Glucose Monitoring System",
        "VivaChek\u2122 Fad Smart Blood Glucose Monitoring System",
        "VivaChek\u2122 Fad Sync Blood Glucose Monitoring System"
    ],
    "Submitter Information": "VivaChek Biotech (Hangzhou) Co., Ltd",
    "510(k) Number": "K222126",
    "Predicate Device Reference 510(k) Number(s)": [
        "K190579"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "July 21, 2023",
    "Summary Letter Received Date": "July 21, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood (fingertip)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VivaChek\u2122 Fad Blood Glucose Meter",
        "VivaChek\u2122 Fad Smart Blood Glucose Meter",
        "VivaChek\u2122 Fad Sync Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry",
        "Electrochemical biosensor"
    ],
    "Methodologies": [
        "Quantitative glucose measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips"
    ],
    "Document Summary": "FDA 510(k) summary for VivaChek\u2122 Fad Blood Glucose Monitoring Systems using electrochemical biosensor technology for quantitative measurement of glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose concentration in fresh capillary whole blood from the fingertip for self-testing by persons with diabetes at home to monitor diabetes control; not for neonatal use or for diagnosis/screening of diabetes; single-user, in vitro diagnostic use.",
    "fda_folder": "Clinical Chemistry"
}